Latest European Expansion News

Page 4 of 7
OncoSil Medical has reported a record quarter for dose sales alongside key European market entries and a successful manufacturing milestone, signalling growing momentum for its pancreatic cancer treatment.
Ada Torres
Ada Torres
30 Jan 2026
Little Green Pharma reports record quarterly revenue and announces a transformative merger with Cannatrek, creating a leading vertically integrated medicinal cannabis group with strong European growth prospects.
Ada Torres
Ada Torres
30 Jan 2026
ECS Botanics reports a $218k positive operating cash flow in Q2 FY26, driven by strong B2C growth and new product launches. The company also secured $1.95 million in funding to fuel European expansion and product development.
Ada Torres
Ada Torres
14 Jan 2026
Sprintex Limited has landed its largest-ever €15.6 million order for ZLD-UP® manure processing systems, marking a pivotal shift from evaluation to commercial deployment across Europe. This multi-year contract sets the stage for substantial revenue growth and a path to profitability in FY26.
Victor Sage
Victor Sage
29 Dec 2025
Collins Foods Limited has reported record half-year revenues of $750.3 million, with underlying net profit after tax surging 29.5%. The company’s operational improvements and expansion in Europe underpin an upgraded FY26 outlook.
Victor Sage
Victor Sage
2 Dec 2025
South Harz Potash Limited (SHP) has secured an option to acquire the Glava copper-gold project in Sweden, complementing its advanced potash development in Germany and reinforcing its multi-commodity European strategy.
Maxwell Dee
Maxwell Dee
28 Nov 2025
AVITA Medical reported a 13% drop in Q3 commercial revenue to $17.1 million but improved its net loss and secured CE Mark approval for RECELL GO in Europe, signaling strategic shifts ahead.
Ada Torres
Ada Torres
7 Nov 2025
Bioxyne Limited has reported a record-breaking first quarter for FY26, with revenues soaring 210% year-on-year, driven by strong demand in cannabis products and strategic European market advances.
Victor Sage
Victor Sage
30 Oct 2025
OncoSil Medical reports a remarkable 917% increase in quarterly cash receipts alongside promising clinical trial results and key European market entries, signaling robust momentum in its pancreatic cancer treatment rollout.
Ada Torres
Ada Torres
30 Oct 2025
Bioxyne Limited has reported a record quarterly revenue of A$14.1 million for Q1 FY26, driven by strong demand in Europe and Australia, alongside a strategic dual listing on the Frankfurt Stock Exchange.
Victor Sage
Victor Sage
30 Oct 2025
Little Green Pharma reported a robust September quarter with revenue exceeding $10 million, driven by growth across all product lines and strong European market performance. The company is poised to benefit from upcoming regulatory reforms and operational efficiencies.
Ada Torres
Ada Torres
30 Oct 2025
Sprintex Limited has transitioned from development to commercial execution, securing major contracts in Europe, China, and India while raising A$1.5m to fund expansion.
Victor Sage
Victor Sage
30 Oct 2025

Browse the archive

Full archive